Wealth Enhancement Advisory Services, LLC Iovance Biotherapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 27,451 shares of IOVA stock, worth $57,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,451
Previous 18,738
46.5%
Holding current value
$57,098
Previous $138,000
34.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$57.8 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$50.8 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$44.1 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$26.4 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$23 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $328M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...